Bryan Ball's most recent trade in Whitehawk Therapeutics Inc. was a trade of 51,020 Common Stock done at an average price of $3.9 . Disclosure was reported to the exchange on May 14, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Whitehawk Therapeutics Inc | Bryan Ball | See remarks | Grant, award, or other acquisition of securities at price $ 3.92 per share. | 14 May 2026 | 51,020 | 448,126 | - | 3.9 | 199,998 | Common Stock |
| Whitehawk Therapeutics Inc | Bryan Ball | See remarks | Sale of securities on an exchange or to another person at price $ 3.64 per share. | 13 Apr 2026 | 92,460 | 397,106 | - | 3.6 | 336,554 | Common Stock |
| Whitehawk Therapeutics Inc | Bryan Ball | See remarks | Sale of securities on an exchange or to another person at price $ 3.46 per share. | 13 Apr 2026 | 26,389 | 489,566 | - | 3.5 | 91,306 | Common Stock |
| Whitehawk Therapeutics Inc | Bryan Ball | See remarks | Sale of securities on an exchange or to another person at price $ 3.57 per share. | 09 Apr 2026 | 50,000 | 522,551 | - | 3.6 | 178,500 | Common Stock |
| Whitehawk Therapeutics Inc | Bryan Ball | See remarks | Sale of securities on an exchange or to another person at price $ 3.43 per share. | 09 Apr 2026 | 6,596 | 515,955 | - | 3.4 | 22,624 | Common Stock |
| Whitehawk Therapeutics Inc | Bryan Ball | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2026 | 366,532 | 0 | - | - | Restricted Stock Units | |
| Whitehawk Therapeutics Inc | Bryan Ball | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2026 | 366,532 | 572,551 | - | - | Common Stock | |
| Whitehawk Therapeutics Inc | Bryan Ball | See remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2026 | 250,058 | 250,058 | - | - | Stock Option (right to buy) | |
| Whitehawk Therapeutics Inc | Bryan Ball | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2026 | 5,000 | 10,000 | - | - | Restricted Stock Units | |
| Whitehawk Therapeutics Inc | Bryan Ball | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2026 | 5,000 | 207,853 | - | - | Common Stock | |
| Whitehawk Therapeutics Inc | Bryan Ball | See remarks | Sale of securities on an exchange or to another person at price $ 3.31 per share. | 01 Mar 2026 | 1,834 | 206,019 | - | 3.3 | 6,070 | Common Stock |
| Whitehawk Therapeutics Inc | Bryan Ball | See remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 366,532 | 366,532 | - | - | Stock Option (right to buy) | |
| Whitehawk Therapeutics Inc | Bryan Ball | See remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 366,532 | 366,532 | - | - | Restricted Stock Units | |
| Whitehawk Therapeutics Inc | Bryan Ball | See remarks | Grant, award, or other acquisition of securities at price $ 2.40 per share. | 01 Mar 2025 | 100,000 | 202,853 | - | 2.4 | 240,000 | Common Stock |
| Whitehawk Therapeutics Inc | Bryan Ball | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 5,000 | 105,000 | - | - | Common Stock | |
| Whitehawk Therapeutics Inc | Bryan Ball | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 5,000 | 15,000 | - | - | Restricted Stock Units | |
| Whitehawk Therapeutics Inc | Bryan Ball | See remarks | Sale of securities on an exchange or to another person at price $ 2.35 per share. | 01 Mar 2025 | 2,147 | 102,853 | - | 2.3 | 5,045 | Common Stock |
| Intercept Pharmaceuticals Inc | Bryan Ball | Chief Qual. Officer & SVP Ops. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.57 per share. | 11 Jul 2022 | 436 | 25,178 (0%) | 0% | 14.6 | 6,353 | Common Stock |
| Intercept Pharmaceuticals Inc | Bryan Ball | Chief Qual. Officer & SVP Ops. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.19 per share. | 11 Apr 2022 | 531 | 25,614 (0%) | 0% | 17.2 | 9,128 | Common Stock |
| Intercept Pharmaceuticals Inc | Bryan Ball | Chief Qual. Officer & SVP Ops. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2022 | 6,100 | 6,100 | - | - | Option to Purchase Common Stock | |
| Intercept Pharmaceuticals Inc | Bryan Ball | Chief Qual. Officer & SVP Ops. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2022 | 3,600 | 26,145 (0%) | 0% | 0 | Common Stock | |
| Intercept Pharmaceuticals Inc | Bryan Ball | Chief Qual. Officer & SVP Ops. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.83 per share. | 11 Jan 2022 | 2,455 | 22,545 (0%) | 0% | 16.8 | 41,318 | Common Stock |